SCR-LIP-000466 · Claim · machine-readable JSON →
In 20 women with lipedema versus 20 healthy controls, lipedema patients demonstrated clinically relevant pain and neuropathic pain features (VAS, LANSS, DN4), with LANSS correlating with VAS (ρ=0.529, p=0.017) and DN4 (ρ=0.521, p=0.018), but the study did not assess fibromyalgia or other chronic-pain comorbidities.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Multidimensional Assessment of Pain and Related Factors In Lipedema: A Controlled Clinical Study. — Gümrük Aslan S, Barış Saklica Ş, Borman P. (2026) ✓ verified — contextual · cross sectional · 2026 · reading confidence: high
“Patients with lipedema demonstrated clinically relevant pain and neuropathic pain features.”
The study characterizes pain and neuropathic pain in lipedema but does not test association with fibromyalgia or other named chronic-pain conditions, so it is on-topic background rather than a direct test of the comorbidity relationship.
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000008
- 2026-11-20 — consolidated · SQ-LIP-000008: evidence moved to SCR-LIP-000619